FreeTender
Accepting bidsitbNorth Macedonia

North Macedonia – Various medicinal products – Procurement of Microbiological Tests

Issued by PHI Institute of Public Health of Republic of North Macedonia Skopje · via TED — Tenders Electronic Daily (EU)

Published
17 Nov 2026
Closes
10 Dec 2026, 23:59 UTC
Reference
799636-2026
Location
North Macedonia
Sector
Healthcare & Pharma
Type
goods

At a glance

PHI Institute of Public Health of Republic of North Macedonia Skopje in North Macedonia has published an invitation to bid in healthcare & pharma: “North Macedonia – Various medicinal products – Procurement of Microbiological Tests”. Submissions close on 10 December 2026, 24 days from today. Quote reference 799636-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 10 notices from this buyer since 2026, 10 of them currently open. There are 33 open healthcare & pharma notices in North Macedonia on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

Details

Procurement of Microbiological Tests

Lots

Lot 1 — 101: Rapid rK39 immunochromatographic test for detection of Leishmania infection

Lot 2 — 102: Rapid test cassette for detection of IgM and IgG antibodies associated with filariasis

Lot 3 — 103: Kovács indole spot test or equivalent

Lot 4 — 104: Staphylococcus aureus ATCC 29213 or equivalent

Lot 5 — 105: Parasite concentration kit with 10% formalin and Triton X fixative, Midi Parasep or equivalent

Lot 6 — 106: Monovalent Shigella O antiserum

Lot 7 — 107: Polyvalent Shigella O antiserum

Lot 8 — 108: Treponema pallidum haemagglutination assay (TPHA) for syphilis

Lot 9 — 109: Urinary Legionella antigen test

Lot 10 — 110: Direct immunofluorescence microscopy test for Chlamydia trachomatis

Lot 11 — 111: Indirect immunofluorescence microscopy test for Leishmania IgM (5 × 10), with coded trays for 10-field indirect immunofluorescence biochip assays, or equivalent Lot 12 — 112: Indirect immunofluorescence microscopy test for Leishmania IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent Lot 13 — 113: Indirect immunofluorescence microscopy test for Rickettsia IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent Lot 14 — 114: Indirect immunofluorescence microscopy test for Echinococcus IgG (5 × 10), with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent Lot 15 — 115: Indirect immunofluorescence microscopy test for Echinococcus IgM, with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

Lot 16 — 116: 11-parameter urine test strips, pack of 100

Lot 17 — 117: Tween 20 additive for phosphate-buffered saline (PBS), premeasured for 1 L of solution, for indirect immunofluorescence test (IIFT) biochip systems

Lot 18 — 118: Venereal Disease Research Laboratory (VDRL) test for syphilis

Lot 19 — 119: VI Rapid Hydatidosis or equivalent immunochromatographic test for detection of antibodies against Echinococcus

Lot 20 — 120: Western blot test for detection of syphilis IgG antibodies

Lot 21 — 121: Western blot test for detection of syphilis IgM antibodies

Lot 22 — 122: Western blot test for IgG antibodies against Toxocara canis, including an update to compatible evaluation software or provision of a compatible scanner and software Lot 23 — 123: Western blot test for IgG and IgM antibodies against Echinococcus, including evaluation software or provision of a compatible scanner and software

Lot 24 — 124: Antiserum against O antigen 11, group F (max. 3 mL)

Lot 25 — 125: Antiserum against O antigens 13 and 22, group G (max. 3 mL)

Lot 26 — 126: Antiserum against O antigens 3, 10, 15 and 19, group E (max. 3 mL)

Lot 27 — 127: Antiserum against O antigen 4, group B (max. 3 mL)

Lot 28 — 128: Antiserum against O antigens 6 and 7, group C1 (max. 3 mL)

Lot 29 — 129: Antiserum against O antigen 8, group C2 (max. 3 mL)

Lot 30 — 130: Antiserum against O antigen 9, group D (max. 3 mL)

Lot 31 — 131: Antiserum against O antigen “Vi” (max. 3 mL)

Lot 32 — 132: Antiserum against O antigens 4 and 12 (max. 3 mL)

Lot 33 — 133: Two-colour agglutination test for detection of antibodies against Entamoeba histolytica in serum, with controls included

Lot 34 — 134: Rapid Rose Bengal test for brucellosis (5 mL), with positive and negative controls and a minimum sensitivity of 25 ± 5 IU/mL

Lot 35 — 135: Bacteriological DNA test kit for E. coli O157, for immunomagnetic separation (100 reactions)

Lot 36 — 136: Rapid test for qualitative detection of Clostridium difficile glutamate dehydrogenase (GDH), toxin A and toxin B antigens in human stool

Lot 37 — 137: Rapid test for qualitative detection of Helicobacter pylori antigen in human stool

Lot 38 — 138: Type A microscopy immersion oil for a 100× oil-immersion objective

Lot 39 — 139: Species-specific indirect immunofluorescence microscopy test for Plasmodium falciparum, P. vivax and P. malariae, with coded reagent trays for 10-field indirect immunofluorescence biochip assays, or equivalent

Lot 40 — 140: Indirect haemagglutination test for quantitative detection of Distoma (Paragonium)

Lot 41 — 141: Indirect haemagglutination test for quantitative serological detection of Fasciola hepatica

Lot 42 — 142: Indirect haemagglutination test for quantitative serological diagnosis of Schistosoma infection

Lot 43 — 143: Indirect haemagglutination test for quantitative serological diagnosis of Trichinella spiralis infection

Lot 44 — 144: Slide incubation cuvettes for indirect immunofluorescence test (IIFT) biochip systems, for slides with 5–10 fields

Lot 45 — 145: Coded reagent trays for 10-field indirect immunofluorescence biochip assays

Lot 46 — 146: Phosphate-buffered saline (PBS), pH 7.2–7.4

Lot 47 — 147: Biological spore indicators for steam sterilisation monitoring (autoclaving), with culture medium and indicator

Lot 48 — 148: Biological spore indicators for dry-heat sterilisation monitoring, with culture medium and indicator

Lot 49 — 149: Indirect immunofluorescence test for detection of IgG and IgM. Each test comprises both IgG and IgM testing, in either a combined or separate format. See the technical specification for details.

Lot 50 — 150: Liquid immunosorbent for indirect immunofluorescence

Lot 51 — 151: Haemagglutination test for serological diagnosis of echinococcosis (Hydatidose Fumouze)

Lot 52 — 152: Amikacin disc, 30 µg

Lot 53 — 153: Amoxicillin, 10 µg

Lot 54 — 154: Ampicillin disc, 2 µg

Lot 55 — 155: Amoxicillin/clavulanic acid, 3 µg

Lot 56 — 156: Amoxicillin/clavulanic acid, 30 µg

Lot 57 — 157: Ampicillin, 10 µg

Lot 58 — 158: Ampicillin/sulbactam, 10/10 µg

Lot 59 — 159: Azithromycin, 15 µg

Lot 60 — 160: Aztreonam disc, 30 µg

Lot 61 — 161: Bacitracin, 10 µg

Lot 62 — 162: Cefadroxil, 30 µg

Lot 63 — 163: Cefepime, 30 µg

Lot 64 — 164: Cefepime/clavulanic acid, 30/10

Lot 65 — 165: Cefixime discs, 5 µg

Lot 66 — 166: Cefotaxime, 30 µg

Lot 67 — 167: Cefotaxime, 5 µg

Lot 68 — 168: Cefoxitin, 30 µg

Lot 69 — 169: Cefpodoxime discs, 10 µg

Lot 70 — 170: Ceftazidime, 10 µg

Lot 71 — 171: Ceftazidime discs, 30 µg

Lot 72 — 172: Ceftriaxone, 5 µg

Lot 73 — 173: Ceftriaxone discs, 30 µg

Lot 74 — 174: Cefuroxime discs, 30 µg

Lot 75 — 175: Chloramphenicol discs, 30 µg

Lot 76 — 176: Clarithromycin, 15 µg

Lot 77 — 177: Clindamycin discs, 2 µg

Lot 78 — 178: Cefaclor, 30 µg

Lot 79 — 179: Cefalexin, 30 µg

Lot 80 — 180: Cefalotin, 30 µg

Lot 81 — 181: Cefotaxime/clavulanic acid, 30/10 µg

Lot 82 — 182: Ceftaroline, 5 µg

Lot 83 — 183: Ceftazidime/clavulanic acid, 30/10 µg

Lot 84 — 184: Ceftazidime/avibactam, 10/4 µg

Lot 85 — 185: Ceftibuten, 30 µg

Lot 86 — 186: Ceftolozane/tazobactam, 30/10 µg

Lot 87 — 187: Ciprofloxacin, 5 µg

Lot 88 — 188: Co-trimoxazole, 25 µg

Lot 89 — 189: Doripenem, 10 µg

Lot 90 — 190: Ertapenem, 10 µg

Lot 91 — 191: Erythromycin (E), 15 µg

Lot 92 — 192: Fusidic acid, 10 µg

Lot 93 — 193: Fosfomycin, 200 µg

Lot 94 — 194: Gentamicin, 10 µg

Lot 95 — 195: Gentamicin, 30 µg

Lot 96 — 196: Imipenem discs, 10 µg

Lot 97 — 197: Levofloxacin, 5 µg

Lot 98 — 198: Linezolid, 10 µg

Lot 99 — 199: Lomefloxacin, 10 µg

Lot 100 — 200: Metronidazole, 5 µg

Buyer: PHI Institute of Public Health of Republic of North Macedonia Skopje

Buyer country: MKD

Procedure: open

CPV code: 33690000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 10 notices from PHI Institute of Public Health of Republic of North Macedonia Skopje, going back to November 2026 — 10 of them still open. They buy mostly in Healthcare & Pharma, Manufacturing & Supply and Energy & Power. There are 33 open Healthcare & Pharma tenders in North Macedonia. This one closes in 24 days.

Explore North Macedonia

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →